The European Coalition to End Animal Experiments has launched a new initiative to introduce animal testing alternatives for cosmetic products in China.
The ECEAE has announced its campaign with concerned companies across the industry, with the goal to gain acceptance in China for the well-established and validated methods that are available as an alternative to cosmetics testing on animals.
ECEAE invited companies to join this campaign whether or not they are already certified under the Humane Cosmetics Standard, in order to get the broadest possible support for its objective to persuade the Chinese government to go down the alternative testing route.
Concerns over alternatives absence
Both animal protection campaigners and the cosmetics industry are very concerned about the absence of alternatives to animal testing for cosmetics in China, with both BUAV and PETA making announcements regarding this in recent months.
As well as concern over the absence of alternatives, campaigners also want the requirement to do additional testing even for products already tested elsewhere to be put in place.
According to ECEAE, this puts industry in a difficult position, since many products have been long accepted around the world and companies are reluctant to see further animal testing take place when the products are already known to be safe.
Open to possible alternatives
However, reports suggest that China is now planning to open the possibility of non-animal alternatives.
Earlier this month PETA announced that through its discussion, China looks poised to accept its first ever non animal test method for cosmetics.
In March, at an inaugural meeting at the BUAV offices in London, representatives of leading cosmetics companies met with representatives from the BUAV and the ECEAE to discuss how progress could be made, with the support of the European Commission and Cosmetics Europe in finding a way forward that would meet the concerns of all sides.
The meeting reached agreement on a number of ways to pursue the issue in partnership and it is hoped to have significant progress to report later this year.